Delivery Order SPE2DB20D6037-SPE2DB25FTWH3
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,121.84 to DMS Pharmaceutical Group Inc. for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe in 0.5 milliliter quantities. The award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,607.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 18, 2025, for ENGERIX-B pediatric hepatitis B vaccine (10 micrograms/0.5 milliliter syringes). This firm fixed-price delivery order carries a ceiling value of $4,243.68 and is scheduled for completion by July 21, 2025. The contract utilizes no set-aside designation, and performance will occur at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract is for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe vaccines in 0.5 milliliter quantities. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation,...
- The Defense Logistics Agency issued a delivery order valued at $8,184.24 to DMS Pharmaceutical Group Inc. for ENGERIX-B PEDI 10 MCG/0.5 syringe pediatric hepatitis B vaccine on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price delivery order was awarded without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The vaccine will be delivered to the Park Ridge location and represents a routine...
- This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,181.70 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. The contract calls for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,668.88 firm fixed-price contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with the DLA, valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,362.08 contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, with a completion date of June 21, 2024. DMS Pharmaceutical Group holds a larger, single-award, indefinite-delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
- This delivery order, valued at $2,175.12, awards DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, a contract for ENGERIX-B 20 MCG/ML vaccine syringes. The Defense Logistics Agency, a defense-focused component of the Department of Defense, funded this award on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract employs firm fixed-price pricing with no set-aside designation, and performance will take place in...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB25FTWH3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,143.85 to DMS Pharmaceutical Group Inc. on September 11, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe (0.5 milliliter), a pediatric hepatitis B vaccine. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. No set-aside designation was utilized for this award. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare facilities nationwide. The performance location for this delivery is Conshohocken, Pennsylvania. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through its comprehensive portfolio of contract awards with the DLA, enabling the agency to efficiently procure medical supplies supporting Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/11/25 |